Genetic evaluation of the azoospermic or severely oligozoospermic male

Current Opinion in Obstetrics and Gynecology

Volumn 24, Issue 4, 2012, Pages 221-228

  Stahl, Peter J ^a   Schlegel, Peter N ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

azoospermia; congenital bilateral aplasia of vas deferens; genetic testing; infertility; karyotype; male

Indexed keywords

BIOLOGICAL MARKER; CHD7 PROTEIN; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GNRH1 PROTEIN; GNRH1R PROTEIN; KAL1 PROTEIN; KISS1R PROTEIN; PROK2 PROTEIN; PROKR2 PROTEIN; TAC3 PROTEIN; TAC3R PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

AZOOSPERMIA; CHROMOSOME ANALYSIS; CHROMOSOME DELETION Y; DISEASE SEVERITY; GENE MUTATION; GENETIC SCREENING; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; KARYOTYPE; OLIGOSPERMIA; PRIORITY JOURNAL; REVIEW;

ADULT; AZOOSPERMIA; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, Y; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE DELETION; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INFERTILITY, MALE; KARYOTYPING; MALE; MUTATION; OLIGOSPERMIA; RISK FACTORS; RNA-BINDING PROTEINS; SEX CHROMOSOME ABERRATIONS; SEX CHROMOSOME DISORDERS OF SEX DEVELOPMENT;

EID: 84863725499     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3283558560     Document Type: Review

References (34)

1. Male Infertility Best Practice Policy Committee of the American Urological Association, Practice Committee of the American Society for Reproductive Medicine. Report on evaluation of the azoospermic male. Fertil Steril 2006; 86:S210-S215.
2. Oates RD. Clinical evaluation of the infertile male with respect to genetic etiologies. Syst Biol Reprod Med 2011; 57:72-77.
3. McLachlan RI, O'Bryan MK. Clinical review: state of the art for genetic testing of infertile men. J Clin Endocrinol Metab 2010; 95:1013-1024.
4. Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Male Reproduction and Urology. The management of infertility due to obstructive azoospermia. Fertil Steril 2008; 90:S121-S124.
5. Morel F, Douet-Guilbert N, Le Bris MJ, et al. Chromosomal abnormalities in couples undergoing intracytoplasmic sperm injection. A study of 370 couples and review of the literature. Int J Androl 2004; 27:178-182.
6. Stahl PJ, Masson P, Mielnik A, et al. A decade of experience emphasizes that testing for Y microdeletions is essential in American men with azoospermia and severe oligozoospermia. Fertil Steril 2010; 94:1753-1756.
7. Hung AJ, King P, Schlegel PN. Uniform testicular maturation arrest: a unique subset of men with nonobstructive azoospermia. J Urol 2007; 178:608-612; discussion 612.
8. Young J. Approach to the male patient with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2012; 97:707-718. Excellent review of the diagnosis and clinical management of males with CHH.
9. Harton GL, Tempest HG. Chromosomal disorders and male infertility. Asian J Androl 2012; 14:32-39.
10. Cystic Fibrosis Genetic Analysis Consortium. www.genet.sickkids.on.ca. updated 2012; accessed March 18, 2012.
11. Radpour R, Gourabi H, Dizaj AV, et al. Genetic investigations of CFTR mutations in congenital absence of vas deferens, uterus, and vagina as a cause of infertility. J Androl 2008; 29:506-513.
12. Mak V, Zielenski J, Tsui LC, et al. Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia. J Am Med Assoc 1999; 281:2217-2224.
13. Giuliani R, Antonucci I, Torrente I, et al. Identification of the second CFTR mutation in patients with congenital bilateral absence of vas deferens undergoing ART protocols. Asian J Androl 2010; 12:819-826.
14. Chu CS, Trapnell BC, Curristin S, et al. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 1993; 3:151-156.
15. Dohle GR, Halley DJ, Van Hemel JO, et al. Genetic risk factors in infertile men with severe oligozoospermia and azoospermia. Hum Reprod 2002; 17:13-16.
16. Bojesen A, Gravholt CH. Klinefelter syndrome in clinical practice. Nat Clin Pract Urol 2007; 4:192-204.
17. Paduch DA, Bolyakov A, Cohen P, Travis A. Reproduction in men with Klinefelter syndrome: the past, the present, and the future. Semin Reprod Med 2009; 27:137-148.
18. Giltay JC, Maiburg MC. Klinefelter syndrome: clinical and molecular aspects. Expert Rev Mol Diagn 2010; 10:765-776.
19. Paduch DA, Fine RG, Bolyakov A, Kiper J. New concepts in Klinefelter syndrome. Curr Opin Urol 2008; 18:621-627.
20. Oates RD. Clinical and diagnostic features of patients with suspected Klinefelter syndrome. J Androl 2003; 24:49-50.
21. Ramasamy R, Ricci JA, Palermo GD, et al. Successful fertility treatment for Klinefelter's syndrome. J Urol 2009; 182:1108-1113.
22. Palermo GD, Colombero LT, Hariprashad JJ, et al. Chromosome analysis of epididymal and testicular sperm in azoospermic patients undergoing ICSI. Hum Reprod 2002; 17:570-575.
23. Martin RH. Cytogenetic determinants of male fertility. Hum Reprod Update 2008; 14:379-390.
24. Mau-Holzmann UA. Somatic chromosomal abnormalities in infertile men and women. Cytogenet Genome Res 2005; 111:317-336.
25. Escudero T, Abdelhadi I, Sandalinas M, Munne S. Predictive value of sperm fluorescence in situ hybridization analysis on the outcome of preimplantation genetic diagnosis for translocations. Fertil Steril 2003; 79 (Suppl 3):1528-1534.
26. McLachlan RI, Aitken RJ, Cram D, et al. Need for standardization and confirmation of STS deletions on the Y chromosome. Fertil Steril 2008; 90:463-464; author reply 464.
27. Hopps CV, Mielnik A, Goldstein M, et al. Detection of sperm in men with Y chromosome microdeletions of the AZFa, AZFb and AZFc regions. Hum Reprod 2003; 18:1660-1665.
28. Kleiman SE, Yogev L, Lehavi O, et al. The likelihood of finding mature sperm cells in men with AZFb or AZFb-c deletions: six new cases and a review of the literature (1994-2010). Fertil Steril 2011; 95:2005-2012; 2012.e1-e4.
29. Oates RD, Silber S, Brown LG, Page DC. Clinical characterization of 42 oligospermic or azoospermic men with microdeletion of the AZFc region of the Y chromosome, and of 18 children conceived via ICSI. Hum Reprod 2002; 17:2813-2824.
30. Patrat C, Bienvenu T, Janny L, et al. Clinical data and parenthood of 63 infertile and Y-microdeleted men. Fertil Steril 2010; 93:822-832.
31. Giachini C, Laface I, Guarducci E, et al. Partial AZFc deletions and duplications: clinical correlates in the Italian population. Hum Genet 2008; 124:399-410.
32. Stahl PJ, Mielnik A, Margreiter M, et al. Diagnosis of the gr/gr Y chromosome microdeletion does not help in the treatment of infertile American men. J Urol 2011; 185:233-237.
33. Eaker S, Cobb J, Pyle A, Handel MA. Meiotic prophase abnormalities and metaphase cell death in MLH1-deficient mouse spermatocytes: insights into regulation of spermatogenic progress. Dev Biol 2002; 249:85-95.
34. Miyamoto T, Hasuike S, Yogev L, et al. Azoospermia in patients heterozygous for a mutation in SYCP3. Lancet 2003; 362:1714-1719.